Literature DB >> 25294165

Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.

Satoshi Kubota1, Masaharu Takigawa1.   

Abstract

CCN family protein 2 (CCN2), also widely known as connective tissue growth factor (CTGF), is one of the founding members of the CCN family of matricellular proteins. Extensive investigation on CCN2 over decades has revealed the novel molecular action and functional properties of this unique signalling modulator. By its interaction with multiple molecular counterparts, CCN2 yields highly diverse and context-dependent biological outcomes in a variety of microenvironments. Nowadays, CCN2 is recognized to conduct the harmonized development of relevant tissues, such as cartilage and bone, in the skeletal system, by manipulating extracellular signalling molecules involved therein by acting as a hub through a web. However, on the other hand, CCN2 occasionally plays profound roles in major human biological disorders, including fibrosis and malignancies in major organs and tissues, by modulating the actions of key molecules involved in these clinical entities. In this review, the physiological and pathological roles of this unique protein are comprehensively summarized from a molecular network-based viewpoint of CCN2 functionalities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25294165     DOI: 10.1042/CS20140264

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  58 in total

1.  Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor.

Authors:  Tian Tian; Aimin Li; Hong Lu; Ran Luo; Mingzhi Zhang; Zhaoming Li
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Come together, right now….

Authors:  Herman Yeger
Journal:  J Cell Commun Signal       Date:  2015-07-25       Impact factor: 5.782

3.  CCN2 induces cellular senescence in fibroblasts.

Authors:  Joon-Ii Jun; Lester F Lau
Journal:  J Cell Commun Signal       Date:  2016-10-18       Impact factor: 5.782

4.  Aortic aneurysm, CCN3 may solve the problem.

Authors:  Yalin Emre; Beat A Imhof
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis.

Authors:  Abdellatif El-Seoudi; Tarek Abd El Kader; Takashi Nishida; Takanori Eguchi; Eriko Aoyama; Masaharu Takigawa; Satoshi Kubota
Journal:  J Cell Commun Signal       Date:  2017-03-25       Impact factor: 5.782

6.  A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.

Authors:  Dongyu Jia; Zhenqiu Liu; Nan Deng; Tuan Zea Tan; Ruby Yun-Ju Huang; Barbie Taylor-Harding; Dong-Joo Cheon; Kate Lawrenson; Wolf R Wiedemeyer; Ann E Walts; Beth Y Karlan; Sandra Orsulic
Journal:  Cancer Lett       Date:  2016-09-05       Impact factor: 8.679

7.  Metabolic regulation of the CCN family genes by glycolysis in chondrocytes.

Authors:  Sho Akashi; Takashi Nishida; Abdellatif El-Seoudi; Masaharu Takigawa; Seiji Iida; Satoshi Kubota
Journal:  J Cell Commun Signal       Date:  2017-11-11       Impact factor: 5.782

8.  Connective tissue growth factor (CTGF/CCN2) in haemophilic arthropathy and arthrofibrosis: a histological analysis.

Authors:  J Jiang; N L Leong; U Khalique; T M Phan; K M Lyons; J V Luck
Journal:  Haemophilia       Date:  2016-10-05       Impact factor: 4.287

9.  A collection of genetic mouse lines and related tools for inducible and reversible intersectional mis-expression.

Authors:  Elham Ahmadzadeh; N Sumru Bayin; Xinli Qu; Aditi Singh; Linda Madisen; Daniel Stephen; Hongkui Zeng; Alexandra L Joyner; Alberto Rosello-Diez
Journal:  Development       Date:  2020-05-28       Impact factor: 6.868

Review 10.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.